Jarrott B, Louis W J, Summers R J
Br J Pharmacol. 1982 Feb;75(2):401-8. doi: 10.1111/j.1476-5381.1982.tb08801.x.
[3H]-guanfacine (N-amidino-2-(2,6-dichloro 3[3H] phenyl) acetamide hydrochloride; 24.2 Ci/mmol) has been used as a radioligand in homogenates of rat cerebral cortex. Specific binding of [3H]-guanfacine was linear with respect to tissue concentration (2.5-15 mg/ml), saturable and not markedly affected in the pH range 6.5-8.0. Analysis of the saturation of [3H]-guanfacine binding using an iterative least squares fitting procedure gave best fits to a single site model. [3H]-guanfacine binding was of high affinity (Kd 1.77 +/- 0.24 nM; n = 8) to a population of non interacting sites (nH 0.99 +/- 0.02; n = 8) with a density of 118.2 +/- 8.4 fmol/mg protein (n = 8). Highest levels of binding were achieved in cerebral cortex followed by thalamus greater than hypothalamus greater than medulla/pons greater than spinal cord greater than striatum greater than cerebellum. Binding was stereoselective with regard to the (-)-isomer of noradrenaline and the order of potency for displacement of [3H]-guanfacine by agonists was naphazoline greater than clonidine greater than (-)-adrenaline greater than (-)-alpha methylnoradrenaline greater than (-)-noradrenaline greater than (+/-)-alpha-methylnoradrenaline greater than (+)-noradrenaline greater than methoxamine greater than (+)-adrenaline greater than phenylephrine and by antagonists was phentolamine greater than dihydroergocryptine greater than piperoxane greater than yohimbine greater than prazosin greater than labetalol greater than indoramin suggested binding to alpha 2-adrenoceptors. The monovalent cations Na+ and K+ and also guanosine 5'-triphosphate (GTP) produced concentration-dependent inhibition whereas the divalent cations Ca2+, Mg2+, and Mn2+ first enhanced, then inhibited [3H]-guanfacine binding. Na+ (150 mM) or GTP (100 microM) produced marked reductions and Mn2+ (5 mM) marked increases in the number of receptor sites labelled by [3H]-guanfacine. 9 It is concluded that [3H]-guanfacine preferentially labels a high affinity state of the alpha 2- adrenoceptor in homogenates of rat cerebral cortex.
[3H]-胍法辛(N-脒基-2-(2,6-二氯-3-[3H]-苯基)乙酰胺盐酸盐;24.2 Ci/mmol)已被用作大鼠大脑皮层匀浆中的放射性配体。[3H]-胍法辛的特异性结合在组织浓度(2.5 - 15 mg/ml)方面呈线性,具有饱和性,并且在pH值6.5 - 8.0范围内不受明显影响。使用迭代最小二乘法拟合程序对[3H]-胍法辛结合的饱和度进行分析,结果最符合单一位点模型。[3H]-胍法辛与一群非相互作用位点具有高亲和力(Kd 1.77 ± 0.24 nM;n = 8)(nH 0.99 ± 0.02;n = 8),密度为118.2 ± 8.4 fmol/mg蛋白质(n = 8)。结合水平在大脑皮层中最高,其次是丘脑大于下丘脑大于延髓/脑桥大于脊髓大于纹状体大于小脑。结合对去甲肾上腺素的(-)-异构体具有立体选择性,激动剂取代[3H]-胍法辛的效力顺序为萘甲唑啉大于可乐定大于(-)-肾上腺素大于(-)-α-甲基去甲肾上腺素大于(-)-去甲肾上腺素大于(±)-α-甲基去甲肾上腺素大于(+)-去甲肾上腺素大于甲氧明大于(+)-肾上腺素大于去氧肾上腺素,拮抗剂的效力顺序为酚妥拉明大于二氢麦角隐亭大于哌罗克生大于育亨宾大于哌唑嗪大于拉贝洛尔大于吲哚拉明,提示与α₂-肾上腺素能受体结合。单价阳离子Na⁺和K⁺以及鸟苷5'-三磷酸(GTP)产生浓度依赖性抑制,而二价阳离子Ca²⁺、Mg²⁺和Mn²⁺首先增强,然后抑制[3H]-胍法辛结合。Na⁺(150 mM)或GTP(100 μM)使[3H]-胍法辛标记的受体位点数量显著减少,Mn²⁺(5 mM)使其显著增加。9得出结论,[3H]-胍法辛优先标记大鼠大脑皮层匀浆中α₂-肾上腺素能受体的高亲和力状态。